ArticleAesthetic plastic surgery2026
Risk Factors and Complication Rates of Inpatient Genioplasty Procedures in the U.S. Healthcare System: A 22-Year Retrospective Multi-center Analysis.
Article in Aesthetic plastic surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Body Mass Index and Risk Stratification in Breast Augmentation: Beyond the Numerical Threshold.Aesthetic plastic surgery · 2026Article
- Comment on "AI-Based Quantitative and Objective Analysis of Aesthetic Results in Genioplasty".Aesthetic plastic surgery · 2026Article
Corrections and comments
- Erratum issued
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundNationwide U.S. data describing inpatient genioplasty outcomes are limited, particularly regarding complication prevalence and predictors. Leveraging HCUP-NIS, this study characterized inpatient complication patterns by procedural approach, age, and socioeconomic markers.
methodsWe conducted a retrospective HCUP‑NIS analysis (2000-2022) of inpatient genioplasty admissions, evaluating demographic, socioeconomic, procedural (osseous vs. non‑osseous), hospitalization (length of stay, charges, discharge), and inpatient‑coded complication variables, with subgroup comparisons by age, income quartile, and procedure type. Stratified univariate and multivariate logistic regression identified independent correlates of inpatient-coded complications.
resultsThe cohort included 485 inpatient genioplasty admissions (mean age 31.8 years; 53.4% female), predominantly privately insured and residing in higher income quartiles. Complications occurred in 10.3% (n = 50), and were higher in older vs. younger patients (14.8% vs. 5.8%; p = 0.002). Osseous genioplasty comprised 63.5% of admissions and showed longer hospitalization, higher charges and higher complication rates versus non-osseous procedures (12.7% vs. 6.2%; p = 0.04). Non‑elective admission, length of stay, and primary payer were independent predictors of complications in the osseous subgroup, whereas in the non‑osseous subgroup, length of stay was the only independent predictor (p < 0.0001).
conclusionIn a nationwide analysis of 485 inpatient genioplasty admissions, complications occurred in ~ 10% of patients, concentrated among older, more comorbid individuals. Prolonged length of stay was the most consistent correlate of complications across techniques, while non-elective admissions increased complication risk and resource use in the osseous subgroup. Lower-income patients experienced longer hospitalizations despite similar complication rates, highlighting persistent socioeconomic disparities. Future, larger-scale prospective trials are warranted to confirm our findings. LEVEL OF EVIDENCE III: Prognostic study. This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.